Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids.

G E Packe, J G Douglas, A F McDonald, S P Robins, D M Reid

Department of Thoracic Medicine, Aberdeen Royal Infirmary.

BACKGROUND: Asthmatic patients taking low to moderate doses of inhaled topical corticosteroids have been shown to have lower bone density than those taking bronchodilators only. There is little information on bone density in asthmatic patients taking high dose inhaled corticosteroids. METHODS: Bone mass was studied in three age matched groups of asthmatic patients. These comprised: 17 asthmatic patients who had never taken inhaled or systemic corticosteroids (group 1); 20 patients who had taken beclomethasone diproprionate in a dosage of 1000-2000 micrograms daily for at least a year, who had also received courses of systemic corticosteroids in the past (group 2); and 20 patients who were taking both high dose inhaled corticosteroids and regular low dose prednisolone, at a median dose of 7 mg daily (group 3). Vertebral bone density was measured by quantitative computed tomography. Biochemical indices of bone formation and resorption were also measured. RESULTS: Mean bone density in group 2 (127.5(22.6) mg/ml) was similar to that in group 3 (114.5 (36.0) mg/ml). Bone density was significantly lower in both of these groups than in group 1 (160.4 (27.4) mg/ml). There were no significant differences between groups for any of the markers of bone formation and resorption. CONCLUSIONS: Asthmatic patients receiving high dose inhaled beclomethasone and intermittent courses of systemic corticosteroids have reduced vertebral bone density. The bone loss is similar in degree to that seen in patients taking high dose inhaled topical corticosteroids and continuous low dose systemic corticosteroids.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Bertoldo, F., Olivieri, M., Franchina, G., De Blasio, F., Lo Cascio, V. (2005). Inhaled Beclomethasone Dipropionate Acutely Stimulates Dose-Dependent Growth Hormone Secretion in Healthy Subjects. Chest 128: 902-905 [Abstract] [Full Text]  
• Smith, B J, McElroy, H J, Laslett, L L, Pile, K D, Phillips, P J, Phillipov, G, Evans, S M, Weekley, J S, Pilotto, L S (2005). Osteoporosis screening in people with airways disease. Chronic Respiratory Disease 2: 5-12 [Abstract]  
• Campbell, I A, Douglas, J G, Francis, R M, Prescott, R J, Reid, D M (2004). Five year study of etidronate and/or calcium as prevention and treatment for osteoporosis and fractures in patients with asthma receiving long term oral and/or inhaled glucocorticoids. Thorax 59: 761-768 [Abstract] [Full Text]  
• Smith, B J, Laslett, L L, Pile, K D, Phillips, P J, Phillipov, G, Evans, S M, Esterman, A J, Berry, J G (2004). Randomized controlled trial of alendronate in airways disease and low bone mineral density. Chronic Respiratory Disease 1: 131-137 [Abstract]  
• Roland, N. J., Bhalla, R. K., Earis, J. (2004). The Local Side Effects of Inhaled Corticosteroids: Current Understanding and Review of the Literature. Chest 126: 213-219 [Abstract] [Full Text]  
• Gluck, O., Colice, G. (2004). Recognizing and Treating Glucocorticoid-Induced Osteoporosis in Patients With Pulmonary Diseases. Chest 125: 1859-1876 [Abstract] [Full Text]  
• Kemp, J. P., Osur, S., Shrewsbury, S. B., Herje, N. E., Duke, S. P., Harding, S. M., Faulkner, K., Crim, C. C. (2004). Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind, Placebo-Controlled Trial. Mayo Clin Proc. 79: 458-466 [Abstract]  
• Leone, F. T., Fish, J. E., Szefler, S. J., West, S. L. (2003). Systematic Review of the Evidence Regarding Potential Complications of Inhaled Corticosteroid Use in Asthma: Collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 124: 2329-2340 [Abstract] [Full Text]  
• Ionescu, A.A., Schoon, E. (2003). Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J 22: 64s-75s [Abstract] [Full Text]  
• Sharma, P. K., Malhotra, S., Pandhi, P., Kumar, N. (2003). Effect of Inhaled Steroids on Bone Mineral Density: A Meta-Analysis. J Clin Pharmacol 43: 193-197 [Abstract] [Full Text]  
• Dubois, E. F., Roder, E., Dekhuijzen, P. N. R., Zwinderman, A. E., Schweitzer, D. H. (2002). Dual Energy X-ray Absorptiometry Outcomes in Male COPD Patients After Treatment With Different Glucocorticoid Regimens*. Chest 121: 1456-1463 [Abstract] [Full Text]  
• Biskobing, D. M. (2002). COPD and Osteoporosis. Chest 121: 609-620 [Abstract] [Full Text]  
• Matsumoto, H., Ishihara, K., Hasegawa, T., Umeda, B.-i., Niimi, A., Hino, M. (2001). Effects of Inhaled Corticosteroid and Short Courses of Oral Corticosteroids on Bone Mineral Density in Asthmatic Patients : A 4-Year Longitudinal Study. Chest 120: 1468-1473 [Abstract] [Full Text]  
• Israel, E., Banerjee, T. R., Fitzmaurice, G. M., Kotlov, T. V., LaHive, K., LeBoff, M. S. (2001). Effects of Inhaled Glucocorticoids on Bone Density in Premenopausal Women. NEJM 345: 941-947 [Abstract] [Full Text]  
• Weiner, P., Berar-Yanay, N., Davidovich, A., Magadle, R. (1999). Nocturnal Cortisol Secretion in Asthmatic Patients After Inhalation of Fluticasone Propionate. Chest 116: 931-934 [Abstract] [Full Text]  
• Lipworth, B. J. (1999). Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis. Arch Intern Med 159: 941-955 [Abstract] [Full Text]  
• LAATIKAINEN, A. K., KROGER, H. P. J., TUKIAINEN, H. O., HONKANEN, R. J., SAARIKOSKI, S. V. (1999). Bone Mineral Density in Perimenopausal Women with Asthma . A Population-based Cross-sectional Study. Am. J. Respir. Crit. Care Med. 159: 1179-1185 [Abstract] [Full Text]  
• BOULET, L.-P., MILOT, J., GAGNON, L., POUBELLE, P. E., BROWN, J. (1999). Long-Term Influence of Inhaled Corticosteroids on Bone Metabolism and Density . Are Biological Markers Predictors of Bone Loss?. Am. J. Respir. Crit. Care Med. 159: 838-844 [Abstract] [Full Text]  
• Hughes, J A, Conry, B G, Male, S M, Eastell, R (1999). One year prospective open study of the effect of high dose inhaled steroids, fluticasone propionate, and budesonide on bone markers and bone mineral density. Thorax 54: 223-229 [Abstract] [Full Text]  
• Nishimura, K., Koyama, H., Ikeda, A., Tsukino, M., Hajiro, T., Mishima, M., Izumi, T. (1999). The Effect of High-Dose Inhaled Beclomethasone Dipropionate in Patients With Stable COPD. Chest 115: 31-37 [Abstract] [Full Text]  
• Keenan, J. M., Bielory, L., Flamion, P. C., Ford, L. B., Murcek, M., Pyszczynski, D. R., Selcow, J., Silvagni, A., Tarpay, M., Zitt, M. J. (1995). Nedocromil in the Outpatient Management of Asthma. Arch Fam Med 4: 835-841 [Abstract]  
• Barnes, P. J. (1995). Inhaled Glucocorticoids for Asthma. NEJM 332: 868-875 [Full Text]  
• Utiger, R. D. (1993). Differences between Inhaled and Oral Glucocorticoid Therapy. NEJM 329: 1731-1733 [Full Text]